UBS analyst Edlain Rodriguez started Berry Global Group with a Buy rating and $67 price target. The company's two most recent acquisitions have improved product mix and increased its resins/raw materials purchasing power, the analyst contends. Rodriguez believes the shares have additional upside.

Berry Global (BERY) and Glatfelter (GLT) announced the achievement of a regulatory milestone in the proposed transaction involving the combination of a majority of Berry's Health, Hygiene and Specialties segment to include its Global Nonwovens and Films business, or HHNF, with Glatfelter, with the expiration of the required waiting period under the Hart-Scott-Rodino, or HSR, Antitrust Improvements Act. As previously announced on February 7, Berry and Glatfelter entered into a definitive agreement under which Berry will spin-off and merge its HHNF business with Glatfelter in a Reverse Morris Trust transaction. The transaction will create a leading, publicly-traded company in the specialty materials industry. The transaction is expected to close in the second half of calendar 2024 and is subject to approval by Glatfelter shareholders and completion of customary closing conditions.